379 related articles for article (PubMed ID: 18622638)
1. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways.
Sun C; Liang C; Ren Y; Zhen Y; He Z; Wang H; Tan H; Pan X; Wu Z
Basic Res Cardiol; 2009 Jan; 104(1):42-9. PubMed ID: 18622638
[TBL] [Abstract][Full Text] [Related]
2. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation endproducts increase EPC apoptosis and decrease nitric oxide release via MAPK pathways.
Shen C; Li Q; Zhang YC; Ma G; Feng Y; Zhu Q; Dai Q; Chen Z; Yao Y; Chen L; Jiang Y; Liu N
Biomed Pharmacother; 2010 Jan; 64(1):35-43. PubMed ID: 19766439
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
5. Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated protein kinase pathways.
Jiang H; Liang C; Liu X; Jiang Q; He Z; Wu J; Pan X; Ren Y; Fan M; Li M; Wu Z
Atherosclerosis; 2010 May; 210(1):71-7. PubMed ID: 20226460
[TBL] [Abstract][Full Text] [Related]
6. Linoleic acid-induced expression of inducible nitric oxide synthase and cyclooxygenase II via p42/44 mitogen-activated protein kinase and nuclear factor-kappaB pathway in retinal pigment epithelial cells.
Fang IM; Yang CH; Yang CM; Chen MS
Exp Eye Res; 2007 Nov; 85(5):667-77. PubMed ID: 17825288
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
Chen J; Huang L; Song M; Yu S; Gao P; Jing J
J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
Mahajan N; Bahl A; Dhawan V
Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro.
Talmor Y; Bernheim J; Klein O; Green J; Rashid G
Eur J Clin Invest; 2008 Aug; 38(8):548-54. PubMed ID: 18717824
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB.
Liu J; Zhao S; Tang J; Li Z; Zhong T; Liu Y; Chen D; Zhao M; Li Y; Gong X; Deng P; Wang JH; Jiang Y
FEBS J; 2009 Aug; 276(16):4598-606. PubMed ID: 19645720
[TBL] [Abstract][Full Text] [Related]
11. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways.
Shen J; DiCorleto PE
Circ Res; 2008 Feb; 102(4):448-56. PubMed ID: 18174464
[TBL] [Abstract][Full Text] [Related]
12. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-kappaB signaling.
Hong MH; Kim MH; Chang HJ; Kim NH; Shin BA; Ahn BW; Jung YD
Life Sci; 2007 May; 80(21):1957-65. PubMed ID: 17379255
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
Ding SZ; Smith MF; Goldberg JB
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
[TBL] [Abstract][Full Text] [Related]
15. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression.
Mendes Sdos S; Candi A; Vansteenbrugge M; Pignon MR; Bult H; Boudjeltia KZ; Munaut C; Raes M
Cell Signal; 2009 Jul; 21(7):1109-22. PubMed ID: 19285553
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 induction via NF-kappaB, p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 pathways in human peripheral blood mononuclear cells by Alloiococcus otitidis.
Harimaya A; Koizumi J; Fujii N; Himi T
Int J Pediatr Otorhinolaryngol; 2007 Sep; 71(9):1465-70. PubMed ID: 17629956
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2.
Chen Q; Dong L; Wang L; Kang L; Xu B
Biochem Biophys Res Commun; 2009 Apr; 381(2):192-7. PubMed ID: 19232321
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F
Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional down-regulation of thromboxane A(2) receptor expression via activation of MAPK ERK1/2, p38/NF-kappaB pathways.
Zhang W; Zhang Y; Edvinsson L; Xu CB
J Vasc Res; 2009; 46(2):162-74. PubMed ID: 18769070
[TBL] [Abstract][Full Text] [Related]
20. Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kappaB.
Lin CC; Lin WN; Wang WJ; Sun CC; Tung WH; Wang HH; Yang CM
Cardiovasc Res; 2009 Jun; 82(3):522-31. PubMed ID: 19233864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
